Richter enhances stake in GZF Polfa to near 100%

20 July 2008

Hungarian drugmaker Richter Gedeon has increased its stake in Polish enterprise, GZF Polfa, to 99.8%. Richter acquired this option in the 2002 privatization of the pharmaceutical enterprise and has now exercised its right to purchase the 29.6% stake in the company that was still owned by the Polish Ministry of Treasury for a fee of 87.3 million zloty ($42.7 million). The Hungarian firm says it will use this near-100% control of the formerly-public firm to further enhance its market position in Poland.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight